These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5045322)

  • 1. [Therapy of hypercholesteremia using beta-pyridylcarbinol in reduced dosage].
    Kaatzsch H
    Med Welt; 1972 May; 23(22):836-7. PubMed ID: 5045322
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hypercholesteremia with beta-pyridylcarbinol. 3. Results of a 5-year supportive therapy].
    Zöllner N; Schmidt-Garve HJ; Wolfram G
    Med Klin; 1971 Mar; 66(13):474-84. PubMed ID: 5558444
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glucose tolerance (glucose infusion test), insulin plasma level and free fatty acids before and following 8-week treatment with beta-pyridylcarbinole in patients with hypercholesteremia].
    Schellenberg B; Schlierf G; Reinheimer W
    Verh Dtsch Ges Inn Med; 1971; 77():563-6. PubMed ID: 5155898
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hypercholesteremia with beta-pyridylcarbinol. I. Biochemistry and clinical results].
    Zöllner N; Gudenzi M
    Med Klin; 1966 Dec; 61(50):1996-2001. PubMed ID: 5994695
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radecol (beta-pyridylcarbinol) therapy in sudden loss of labyrinth function. 1. Results of therapy of the so-called "acute" hearing drop].
    Unger E; Gramowski KH; Ehrig J
    Dtsch Gesundheitsw; 1972 Mar; 27(13):610-3. PubMed ID: 5040776
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy with Radecol (beta-pyridylcarbinol) in sudden loss of labyrinth function. 2. Therapy results in sudden unilateral vestibular deficit].
    Unger E; Gramowski KH; Ehrig J
    Dtsch Gesundheitsw; 1972 Dec; 27(51):2438-40. PubMed ID: 4650697
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy in hypercholesteremia].
    Heyden-Stucky S
    Schweiz Med Wochenschr; 1967 Apr; 97(14):451-63. PubMed ID: 5587006
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid and carbohydrate metabolism in diabetics with hypercholesteremia during long-term treatment with beta-pyridylcarbinol].
    Wandrey H; Geser CA; Zöllner N
    Med Klin; 1970 Apr; 65(14):668-76. PubMed ID: 5507801
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of hypercholesterolemia with beta-pyridylcarbinol. Part 5. Report on 16 cases with severe hypercholesterolemia treated for 12 years.
    Zöllner N; Keller CH; Wolfram G
    Atherosclerosis; 1977 Apr; 26(4):611-5. PubMed ID: 856228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of beta-pyridyl carbinol (Ronicol Timespan)].
    Kobayashi K; Shibata M; Kato K; Kawaguchi S; Sasa R
    Saishin Igaku; 1969 Dec; 24(12):2530-4. PubMed ID: 5363412
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hypercholesterinemia with beta-pyridylcarbinol. II. Side effects and disscussion].
    Zöllner N; Gudenzi M
    Med Klin; 1966 Dec; 61(51):2036-40. PubMed ID: 5996572
    [No Abstract]   [Full Text] [Related]  

  • 12. Practical possibilities for lowering serum cholesterol. Results of a double-blind study.
    Nelemans FA
    Nutr Metab; 1973; 15(1):151-3. PubMed ID: 4576165
    [No Abstract]   [Full Text] [Related]  

  • 13. Principles of drug therapy of hyperlipidemic xanthomatous diseases.
    Zöllner N
    Nutr Metab; 1973; 15(1):144-50. PubMed ID: 4576164
    [No Abstract]   [Full Text] [Related]  

  • 14. [A delayed-action therapeutic agent in chronic cerebral circulatory insufficiencies].
    Boudouresques J; Papy JJ; Daniel F
    Therapeutique; 1970 Oct; 46(8):789-92. PubMed ID: 5458910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arteriosclerosis--nicotinic acid therapy. 9. Treatment of hypercholesteremia].
    Selvaag O
    Lakartidningen; 1971 Apr; 68(15):1768. PubMed ID: 5577251
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of a new drug for the treatment of atherosclerosis: pirozadil (722-D) (author's transl)].
    Marín Plaza R; Díaz González JM; Varela de Seijas JR
    Med Clin (Barc); 1982 May; 78(10):427-32. PubMed ID: 7047924
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hypercholesteremia with cholestyramine, a bile acid sequestering resin.
    Casdorph HR
    Vasc Dis; 1967 Oct; 4(5):305-8. PubMed ID: 6051118
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of nicotinyl alcohol alone and in combination with various drugs in the therapy of nerve root syndromes not induced by mechanic compression].
    Cuscani R; Paravizzini D
    Orizz Ortop Odie Riabil; 1967; 12(1-4):179-85. PubMed ID: 5621227
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia.
    Matsuo T; Iwade K; Hirata N; Yamashita M; Ikegami H; Tanaka N; Aosaki M; Kasanuki H
    Heart Vessels; 2005 Feb; 20(1):8-12. PubMed ID: 15700196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of a new drug association on hypercholesteremia studied with a controlled clinical trial].
    Manaresi A
    Clin Ter; 1971 Mar; 56(6):523-34. PubMed ID: 5131092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.